期刊文献+

脂联素在糖调节受损患者冠状动脉病变风险中的意义 被引量:3

Significance of adiponectin in the risk of coronary lesions in patients with impaired glucose regulation
原文传递
导出
摘要 目的探讨脂联素在不同糖调节受损者冠脉病变发生及严重程度中的临床意义。方法疑似冠心病行冠脉造影者210例,分为正常血糖组(NGT)42例,空腹血糖调节受损组(IFG)36例,糖耐量受损组(IGT)92例(其中IGTl组44例2h血糖〈10mmol/L;IGT2组48例2h血糖≥10mmol/L),IFG+IGT组40例。检测体重指数、血压、血脂、胰岛素、脂联素、C反应蛋白,并进行Gensini评分。结果IGT、IFG+IGT组冠心病患病率及Gensini评分显著高于IFG及NGT(P〈0.05);脂联素在IGT、IFG+IGT两组中显著低于IFG、NGT组(P〈0.05),C反应蛋白在IGT、IFG+IGT两组显著升高(P〈0.05);IGT2组较IGTl组Gensini显著升高、脂联素显著下降(P〈0.05);Gensini与脂联素负相关,与C反应蛋白、HOMA—IR正相关(P〈0.05):多因素逐步回归分析显示脂联素和HOMA.IR是冠脉病变严重程度独立影响因素。结论低脂联素血症可更敏感地预测IGR患者的冠脉病变程度,尤其在IGT组中,如餐后血糖控制在10mmol/L以下可能会带来更大的心血管获益. Objective To investigate the association of impaired glucose regulation and adiponectin (APN) with the clinical severity of coronary lesions. Methods A total of 210 cases of suspected coronary heart disease were examined by coronary artery angiography. The patients were differentiated as 4 groups : 42 patients with normal glucose tolerance ( NGT), 36 patients with impaired fasting glucose ( IFG), 92 patients with impaired glucose tolerance ( IGT; including 44 cases with postpraudial 2h plasma glucose(2 hPG) 〈 10 mmol/L as IGT1 subgroup and 48 cases with 2h PG i〉 10 mmol/L as IGT2 subgroup), and 40 patients with combination of IFG and IGT. Accordingly, body mass index ( BMI), blood pressure, blood lipid, insulin, APN and CRP were measured to evaluate by Gensini score. Results The incidence of coronary heart disease and Gensini scores in IGT and IGT+IFG groups were significantly higher than those in either IFG or NGT subset( P〈0.05 ). APN in both IGT and IGT+IFG subsets was significantly lower than that in IFG or NGT subsets( P〈0.05 ) , CRP values were significantly raised in both IGT and IGT+IFG subgroups compared with tile other 2 subgroups ( P〈0.05 ). Statistical difference in Gensini scores and APN was found between the 2 IGT subgroups (P〈 0.05 ). Gensini scores were negatively cmTelated with APN level. Multivariate regression analysis showed that both APN and HOMA-IR values were independently correlated with the Gensini scores. Conclusion The lowered APN may serve as a more sensitive factor in predicting the coronary lesions in patients with IGR, especially in IGT eases. It woula be beneficial to cardiovascular complication by controlling the postprandial blood glucose level below 10 mmol/L.
出处 《中华内分泌代谢杂志》 CAS CSCD 北大核心 2012年第12期984-988,共5页 Chinese Journal of Endocrinology and Metabolism
基金 上海市卫生局科研课题(20124248)
关键词 糖调节受损 空腹血糖受损 糖耐量受损 脂联素 C反应蛋白 GENSINI评分 Impaired glucose regulation hnpaired fasting glucose hnpaired glucose tolerance Adiponectin C-reactive protein Gensini score
  • 相关文献

参考文献27

  • 1Amini M,Janghorbani M. Diabetes and impaired glucose regulation in first-degree relatives of patients with type 2 diabetes in Isfahan, Iran: prevalence and risk factors. Rev Diabet Stud, 2007,4: 169-176.
  • 2Yang W, LuJ, WengJ, et al. Prevalence of diabetes among men and women in China. N EnglJ Med, 2010,362: 1090-1101.
  • 3Szostak - W egierek D, Szamotulska K. Fetal development and risk of cardiovascular diseases and diabetes type 2 in adult life. Med Wieku Rozwoj, 2011,15 :203-215.
  • 4Kadowaki T, Yamauchi T. Adiponectin receptor signaling: a new layer to the current model. Cell Metab, 2011 , 13 : 123 -124.
  • 5Gensini GG. A more meaningful scoring system for determining the severity of coronary heart disease. AmJ Cardio, 1983,51 :606-606.
  • 6Aydin Y, Berker D, Ustiin I, et al. Evaluation of carotid intima media thickness in impaired fasting glucose and impaired glucose tolerance. Minerva Endocrinol, 2011 ,36: 171-179.
  • 7Kataoka Y , Yasuda S, Morii I, et al. Quantitative coronary angiographic studies of patients with angina pectoris and impaired glucose tolerance. Diabetes Care, 2005,28 :2217 -2222.
  • 8Karasik A. Glycaemic control is essential for effective cardiovascular risk reduction across the type 2 diabetes continuum. Ann Med, 2005, 37 :250-258.
  • 9Nikolopoulou A, Kadoglou NP. Obesity and metabolic syndrome as related to cardiovascular disease. Expert Rev Cardiovasc Ther, 2012, 10 :933-939.
  • 10宁光,顾卫琼,徐敏,杜鹏飞,洪洁,张翼飞,李小英.脂联素:从胰岛素抵抗到胰岛β细胞功能[J].中华内分泌代谢杂志,2004,20(4). 被引量:12

二级参考文献89

共引文献144

同被引文献31

  • 1Desiree Wanders,Eric P Plaisance,Robert L Judd.Pharmacological effects of lipid-lowering drugs on circulating adipokines[J].World Journal of Diabetes,2010,1(4):116-128. 被引量:5
  • 2姜玲玲,洪小飞,厉有名.血清脂联素与肥胖和非酒精性脂肪性肝病关系的研究[J].中华消化杂志,2005,25(4):238-239. 被引量:13
  • 3余玲玲,周乃珍,陈治卿.老年高尿酸血症与胰岛素抵抗的关系[J].中国糖尿病杂志,2007,15(8):466-467. 被引量:24
  • 4Kashyap S, Belfort R, Gastaldelli A, et al. A sustained increase in plasma free fatty acids impairs insulin secretion in nondiabetic subjects genetically predisposed to develop type2 diabetes. Diabetes, 2003,52 : 2461-2474.
  • 5Feher M, Greener M, Munro N. Persistent hypertriglyceridemia in statin-treated patients with type 2 diabetes mellitus. Diabetes Metab Syndr Obes, 2013,6 : 11-15.
  • 6Pedro Marques-Vidal, Remy Schmid, Murielle Bochud, et al. Adipocytokines, hepatic and inflammatory biomarkers and incidence of type 2 diabetes. The CoLaus Study. PLoS One, 2012,7: e51768. Published online 2012 December 12. doi: 10. 1371/journal. pone. 0051768 PMCID, PMC3520903.
  • 7Zhang S, Liu Y, Li Q, et al. Exercise improved rat metabolism by raising PPAR-c-. Int J Sports Med, 2011,32:568-573.
  • 8Alborn WE, Johnson MG, Prince MJ, et al. Definitive N-terminal protein sequenee and further characterization of the novel apolipoprutein A5 in human serum. Clin Chem, 2006,52:514-517.
  • 9Le Roith D. β-cell dysfunction and insulin resistance in type 2 diabetes : role of metabolic and genetic abnormalities. Am J Med, 2002, 113 ( Suppl 6A) :3S-11S.
  • 10Reuben A. Long-term management of the liver transplant patient:diabetes, hyperlipidemi a, and obesity. Liver Transpl, 2001,7 ( 11 Suppll ) :S13-S21.

引证文献3

二级引证文献14

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部